Long-term use of mizoribine in rheumatoid arthritis patients on hemodialysis

Modern Rheumatology

Volumn 11, Issue 2, 2001, Pages 132-135

  Saisho, Koichiro ^a   Kurosawa, Osamu ^a   Fukanoki, Tsuyoshi ^a   Hanafusa, Akinori ^b   Tajima, Naoya ^c  

^a Kokuritsu Miyakonojo Hospital   (Japan)

^b Hanafusa Urology Hospital   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Disease modifying antirheumatic drug; Hemodialysis; Mizoribine; Rheumatoid arthritis

Indexed keywords

EID: 33847215353     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s101650170024     Document Type: Article

References (11)

1. Lansbury J. Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis: theoretic and clinical considerations. Arthritis Rheum 1958;1:505-22.
2. Hamada K. The safety of Actarit (Mover) in hemodialysis patients with rheumatoid arthritis (in Japanese). Prog Med 1997;17:1652-7.
3. Kaizu K, Komine N, Uriu K, Ikeda M, Hashimoto O, Eto S. Bucillamine may be an effective anti-rheumatic drug in patients with end-stage renal disease - a case report (in Japanese). J Jpn Soc Dial Ther 1994;27:1505-10.
4. Matthey F, Perrett D, Greenwood RN, Baker LRI. The use of dpenicillamine in patients with rheumatoid arthritis undergoing hemodialysis. Clin Nephrol 1986;25:268-71.
5. Nakayama K. Administration of mizoribine to patients on maintenance hemodialysis accompanied by rheumatoid arthritis (in Japanese). Miyazaki Ikai-shi 1994;18:203-9.
6. Nakamura K, Sakemi T, Nagasawa K. Severe pancytopenia caused by a single administration of low-dose methotrexate in a patient undergoing hemodialysis. J Rheumatol 1999;26:1424-5.
7. Warabi H, Abe S, Kondo H, Ishihara Y, Sugawara S, Shichikawa K, et al. Consecutive administration of mizoribine in rheumatoid arthritis. Pharmacokinetic study (in Japanese). Rheumatology 1991;5:287-300.
8. Sonda K, Takahashi K, Tanabe K, Ohta K. Optimal dose of mizoribine for renal transplantation patients (in Japanese). Ther Res 1995;16:998-1003.
9. Kashiwazaki S, Kondo H, Koike T, Saito T, Kasukawa R, Kashiwagi H, et al. Dose comparison of Bredinin on rheumatoid arthritis: a multicenter post-marketing surveillance study (in Japanese). Jpn J Inflamm 1996;16:269-89.
10. Kohriyama K, Kohno A, Shiozawa K, Shiozawa S. The effectiveness of using Mizoribine to treat rheumatoid arthritis. A long term administration study (in Japanese). Clin Rheumatol 1994;6:123-51.
11. Kusaba R, Otubo O, Inou T, Tsujino M, Ishikawa H. Studies of pharmacokinetics of bredinin (in Japanese). Jpn J Transplant 1982;17 Suppl:S585-93.